Results 71 to 80 of about 3,139 (175)

Non-viral Smad7 gene delivery and attenuation of postoperative peritoneal adhesion in an experimental model [PDF]

, 2009
Background: Postoperative intra-abdominal adhesion is associated with high morbidity and mortality. Smad7, a protein that occupies a strategic position in fibrogenesis, inhibits the transforming growth factor (TGF) β/Smad signalling pathway.
Chan, LYY, Cheung, JS, Guo, H, Lai, KN, Leung, JCK, Wu, EX   +5 more
core   +1 more source

The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout

Nephrology, Volume 29, Issue 8, Page 547-550, August 2024.
Abstract Gout affects 15%–30% of individuals with advanced kidney disease. Allopurinol which is rapidly and extensively metabolised to an active metabolite, oxypurinol, is the most commonly prescribed urate‐lowering therapy. Oxypurinol is almost entirely eliminated by the kidneys (>95%) and has an elimination half‐life of 18–30 h in those with normal ...
Luke C. Wilson, Jacob Ward, Daniel F. B. Wright, Suetonia C. Green, Sophie L. Stocker, Tracey L. Putt, John B. W. Schollum, Robert J. Walker   +7 more
wiley   +1 more source

Icodextrin reduces adhesion formation following gynecological surgery in rabbits [PDF]

Iranian Journal of Reproductive Medicine, 2011
Background: Adhesion is a common complication of gynecology surgery so different barrier agents and solutions have been used during these operations to separate and protect tissues from adhesion after surgery.
Behnaz Khani1, Nahid Bahrami, Ferdous Mehrabian, Hormoz Naderi Naeni   +3 more
doaj  

Peritoneal Dialysis Guidelines 2019 Part 2: Main Text (Position paper of the Japanese Society for Dialysis Therapy)

Renal Replacement Therapy, 2021
Background This article is a duplicated publication from the Japanese version of “2019 JSDT Guidelines for Peritoneal Dialysis” with permission from the Japanese Society for Dialysis Therapy (JSDT).
Munekazu Ryuzaki, Yasuhiko Ito, Hidetomo Nakamoto, Yuichi Ishikawa, Noritomo Itami, Minoru Ito, Atsushi Ueda, Yoshie Kanazawa, Hideki Kawanishi, Yoshihiko Kanno, Hitoshi Sugiyama, Kazuhiko Tsuruya, Hiroyuki Terawaki, Tadashi Tomo, Mizuya Fukasawa, Akihiro C. Yamashita, Hideki Yokoi, Masaaki Nakayama, Hidemichi Yuasa, Yasushi Tsujimoto, Hiraku Tsujimoto, Yosuke Saka, Yusuke Kuroki, Kaoru Yasuda, Takayuki Fujii, Atsuhiro Kanno, Emi Fujikura, Kimio Watanabe, Yoko Obata, Miho Murashima, Naohiro Toda, Shuto Yamamoto, Yoshihiro Tsujimoto, Tsutomu Sakurada, Daisuke Komukai, Kiyotaka Uchiyama, Naoki Washida, Kohkichi Morimoto, Takahiro Kasai, Yukio Maruyama, Chieko Higuchi, Hiroaki Io, Keiichi Wakabayashi, on behalf of the Working Group on Revision of Peritoneal Dialysis Guidelines of the Japanese Society for Dialysis Therapy   +43 more
doaj   +1 more source

A prospective, randomized, multicenter, open‐label trial comparing survival in subjects receiving peritoneal dialysis or conventional in‐center hemodialysis

Medicine Advances, Volume 2, Issue 2, Page 112-122, June 2024.
Abstract Background Peritoneal dialysis (PD) and conventional in‐center hemodialysis (HD) are treatment options for patients with end‐stage kidney disease (ESKD). However, their impact on all‐cause mortality is unclear. Methods We conducted a multicenter, open‐label, randomized, non‐inferiority trial to determine the effect of dialysis modality on ...
Li Fan, Xiao Yang, Huaying Shen, Menghua Chen, Hao Zhang, Zhaohui Ni, Hongli Lin, Hongtao Yang, Qinkai Chen, Hongyu Chen, Gengru Jiang, Jianqin Wang, Jiuyang Zhao, Zhuxing Sun, Aiping Yin, Aili Jiang, Yun Li, Hui Peng, Nan Chen, Chuanming Hao, Yaozhong Kong, Rong Rong, Jie Li, Xia Zou, Haotian Luo, Jiaqi Qian, Xueqing Yu   +26 more
wiley   +1 more source

A Novel Diagnostic Approach for Suspected Icodextrin Pleural Effusion in a Peritoneal Dialysis Patient

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2019
Symptomatic pleural effusion secondary to pleuroperitoneal communication in patients undergoing peritoneal dialysis (PD) occurs in approximately 2% of patients undergoing continuous ambulatory PD.
Macaulay Amechi Chukwukadibia Onuigbo, MD, MSc, FWACP, FASN, MBA, Nneoma Agbasi, RMN, MSc, PG Dip, Kramer Wahlberg, MD, Bibek Karki, MD, Sana Khan, MD   +4 more
doaj   +1 more source

Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis [PDF]

, 2013
Transglutaminase type 2 (TG2) is an extracellular matrix crosslinking enzyme with a pivotal role in kidney fibrosis. The interaction of TG2 with the heparan sulfate proteoglycan syndecan-4 (Sdc4) regulates the cell surface trafficking, localization, and ...
Burhan, I, Funck, M, Huang, L, Johnson, TS, Scarpellini, A, Schroeder, N, Verderio, EAM   +6 more
core   +1 more source

Differential effects of biocompatible peritoneal dialysis fluids on human mesothelial and endothelial cells in 2D and 3D phenotypes

Artificial Organs, Volume 48, Issue 5, Page 484-494, May 2024.
Abstract Introduction Peritoneal dialysis (PD) is a life maintaining treatment in patients with end‐stage renal disease. Its chronic application leads to peritoneal mesothelial layer denudation and fibrotic transformation along with vascular activation of inflammatory pathways. The impact of different PD fluids (PDF) on mesothelial and endothelial cell
Rajesh M. Jagirdar, Eleanna Pitaraki, Erasmia Rouka, Eleftherios D. Papazoglou, Maria Bartosova, Pantelis Zebekakis, Claus Peter Schmitt, Sotirios G. Zarogiannis, Vassilios Liakopoulos   +8 more
wiley   +1 more source

Dialysis in the acute setting [PDF]

, 2015
Acute kidney injury (AKI) is frequently encountered in the hospital setting. It may be present on admission or may develop during the hospital stay. Early and consistent recognition of AKI has been a challenge.
Malhotra, Kunal
core  

A generalized linear model for cardiovascular complications prediction in PD patients [PDF]

, 2018
[Abstract] This study was conducted using machine learning models to identify patient non-invasive information for cardiovascular complications prediction in peritoneal dialysis patients. Nowadays is well known that cardiovascular diseases are the key to
Alonso Valente, Rafael, Fernández-Lozano, Carlos, Fidalgo Díaz, Manuel, Pazos, A.   +3 more
core   +1 more source